Cite
HARVARD Citation
Okazuka, K. et al. (2020). The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma. European journal of haematology. pp. 110-115. [Online].